Pre-exposure prophylaxis as prevention strategy in the HIV transmission: characterization of the user
DOI:
https://doi.org/10.26694/repis.v8i.2220Palabras clave:
Medication Adherence, HIV, Patients, Pre-Exposure ProphylaxisResumen
Introduction: The combined HIV prevention is the current strategy of prevention employed in coping with this disease. It makes combined use of biomedical, behavioral and structural interventions, applied at the level of individuals. This study aimed to characterize the user of PrEP of a hospital of Minas Gerais and his relationship with this proposal. Outline: Descriptive study based on secondary data, with a quantitative approach, carried out in 2020. To obtain the data, information available by the service itself, in the prophylactic care of users, was used. Results: Of the 80 users analyzed, 41.3% were between 22 and 30 years old, 86.3% were single and 80% considered themselves homosexuals, 37.5% claimed to have had a relationship with HIV+ people without using condoms, 100% of users underwent rapid testing for HIV. Implications: The findings demonstrate that PrEP has significantly contributed to HIV prevention. However, given the risk behavior of many users, there is a need for managers and health professionals to improve this intervention.
Citas
Abreu SRP, Beatriz M, Silva NM, Moura LRP, Brito CMS, Câmara JT. Estudo epidemiológico de pacientes com infecção pelo vírus da imunodeficiência humana/ síndrome da imunodeficiência adquirida (HIV/AIDS), CAXIAS- MA. R Inter online [Internet]. 2016 Out Nov Dez [citado 2020 Mar 10]; 9(4):132-141. Disponível em: https://revistainterdisciplinar.uninovafapi.edu.br/index.php/revinter/article/view/1227
Brasil. Ministério da Saúde Secretaria de Vigilância em Saúde Departamento de Vigilância, Prevenção e Controle das Infecções Sexualmente Transmissíveis, do HIV/AIDS e das Hepatites Virais. Relatório de monitoramento clínico do HIV. Brasília, DF: Ministério da Saúde; 2018. Disponível em: http://www.aids.gov.br/pt-br/pub/2018/relatorio-de-monitoramento-clinico-do-hiv-2018
Wolffenbüttel K, Carneiro N. Uma breve história dos Centros de Testagem e Aconselhamento (CTA) enquanto organização tecnológica de prevenção de DST/Aids no Brasil e no estado de São Paulo. Saúde Col [Internet]. 2007 [citado 2020 Mar 20]; 4(18): 183-187. Disponível em: https://www.redalyc.org/pdf/842/84218406.pdf
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância, Prevenção e Controle das Infecções Sexualmente Transmissíveis, do HIV/Aids e das Hepatites Virais. Manual Técnico de Elaboração da Cascata de Cuidado Contínuo do HIV. Brasília, DF: Ministério da Saúde; 2017. Disponível em: http://www.aids.gov.br/pt-br/pub/2017/manual-tecnico-de-elaboracao-da-cascata-de-cuidado-continuo
Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O'Reilly KR, Koechlin FM, et al. Effectiveness and safety of oral HIV pre-exposure prophylaxis (PrEP) for all populations: A systematic review and meta-analysis. AIDS [Internet].2016 Jul [citado 2020 Abr 05];30(12):1973-83. Disponível em: https://doi.org/10.1097/QAD.0000000000001145
Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med [Internet].2010 Dez [citado 2020 Abr 20];363(27):2587-99. Disponível: https://doi.org/10.1056/NEJMoa1011205
Baral SD, et al. Male sex workers: practices, contexts, and vulnerabilities for HIV acquisition and transmission. Lancet[Internet]. 2015 Dez [citado 2020 Set 20]; 385 (9964): 260-73. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504188/pdf/nihms656919.pdf
Queiroz AAFLN, Sousa AFL, Matos MCB, Araújo TM, Reis RK, Moura MEB, et al. Knowledge about HIV/AIDS and implications of establishing partnerships among Hornet® users. Rev Bras Enferm [Internet]. 2018 [citado 2020 Mai 22]; 71(4):1949-55. Disponível em https://doi.org/10.1590/0034-7167-2017-0409
Kerr L, Kendall C, Guimarães MDC, Mota RS, Veras MA, Dourado I, et al. HIV prevalence among men who have sex with men in Brazil: results of the 2nd national survey using respondentdriven sampling. Medicine (Baltimore) [Internet]. 2018 Mai [citado 2020 Jun 11]; 97(1):9–15. Disponível em: https://doi.org/10.1097/MD.0000000000010573
Unaids. Communities at the Centre. [Internet]. 2019 [citado 2020 Jul 12]. Disponível em: https ://www.unaid s.org/sites /default/files /media asset/2019-globa l-AIDSupdate_en.pdf
Luz PM, Torres TS, Almeida-Brasil CC, Marins LMS, Veloso VG, Grinsztejn B, et al. High-Risk Sexual Behavior, Binge Drinking and Use of Stimulants are Key Experiences on the Pathway to High Perceived HIV Risk Among Men Who Have Sex with Men in Brazil. AIDS Behavior [Internet].2020 Set. [citado 2020 Jun 02]. Disponível em: https://doi.org/10.1007/s10461-020-03035-5
MoraisAMF, Silva JB, Silva AG, Alvim HGO. Profilaxia pré-exposição a HIV – revisão de literatura. Rer Inic Cient Ext [Internet]. 2019 [citado 2020 Jun 15]; 2(1):62-8. Disponível em: https://revistasfacesa.senaaires.com.br/index.php/iniciacao-cientifica/article/view/144/99
MccormackS, Dunn DT,Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): Effectiveness results from the pilot phase of a pragmatic open-label randomi-sed trial. Lancet [Internet]. 2016 Jan [citado 2020 Jul 02]; 387(10013):53–60. Disponível em: https://doi.org/10.1016/S0140-6736(15)00056-2
MolinaJ-M, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med [Internet]. 2015 Dez [citado 2020 Jul 23];373(23):2237–46. Disponível em: https://doi.org/10.1056/NEJMoa1506273
BergoPHF, Bianchini T, Alves CG, Ribeiro Júnior A, Beck EK, Rigatto MHP. Profilaxia pré-exposição no controle do HIV: uma revisão de efetividade e potenciais complicações. Acta méd. (Porto Alegre) [Internet]. 2018 [citado 2020 Ago 04]; 39(1):225-34. Disponível em: https://ebooks.pucrs.br/edipucrs/acessolivre/periodicos/acta-medica/assets/edicoes/2018-1/arquivos/pdf/18.pdf
Liu AY, Cohen S, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, et al. HIV Pre-Exposure Prophylaxis Integrated with Municipal and Community Based Sexual Health Services. JAMA Intern Med [Internet]. 2016 Jan [citado 2020 Ago 23];176(1):75–84. Disponível em: https://doi.org/10.1001/jamainternmed.2015.4683
Nguyen V-K, Greenwald ZR, Trottier H, Cadieux M, Goyette A, Beauchemin M, et al. Incidence of sexually transmitted infections before and after pre-exposure prophylaxis for HIV. AIDS [Internet]. 2018 Jan [citado 2020 Set 03];32(4):523–30. Disponível em: https://doi.org/10.1097/QAD.0000000000001718
HosekSG, Landovitz RJ, Kapogiannis B, Siberry GK, Rudy B, Rutledge B, et al. Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States. JAMA Pediatrics [Internet]. 2017 Nov [citado 2020 Out 10]; 171(11);1063-71. Disponível em: https://doi.org/10.1001/jamapediatrics.2017.2007
ZucchiEM, Grangeiro A, Ferraz D, Pinheiro FT, Alencar T, Ferguson L, et al. Da evidência à ação: desafios do Sistema Único de Saúde para ofertar a profilaxia pré-exposição sexual (PrEP) ao HIV às pessoas em maior vulnerabilidade. Cad. Saúde Pública [Internet]. 2018 [citado 2020 Nov 11]; 34(7):1-12. Disponível em: https://doi.org/10.1590/0102-311x00206617
Hoagland B, Moreira RI, De Boni RB, Kallas EG, Madruga JV, Vasconcelos R, et al. High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV infection: the PrEP Brasil demonstration project. Journal of the International AIDS Society [Internet]. 2017 Abr; 20(1):21472. Disponível em: https://doi.org/10.7448/IAS.20.1.21472
